The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer
โ Scribed by Miyun Oh; Jeong-Yeon Lee; Dong-Hui Shin; Ji-Hye Park; Tingting Oian; Hyun-Jun Kim; Sung-Dae Cho; Seung-Hyun Oh; Young Ki Min; Gu Kong
- Book ID
- 108586989
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 796 KB
- Volume
- 102
- Category
- Article
- ISSN
- 1347-9032
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Prolonged hypoxia induced transient drug resistance in Chinese hamster lung fibroblasts. Previously hypoxic cells were resistant to adriamycin and resistant to etoposide. Complete recovery of etoposide sensitivity was observed following reโaeration for 24 hr. A change in Pโglycoprotein
The effects of the novel anti-estrogen EM-343 on the growth of 2 hormone-responsive human breast cancer tumors have been examined in athymic nude mice. At the low daily dose of 5 g, EM-343 administered subcutaneously for 6 months completely blocked the stimulatory effect of endogenous estrogens on t
## Abstract ## Purpose To investigate the heterogeneity in the angiogenic response of a human breast cancer xenograft to a novel vascular endothelial growth factor (VEGF)โreceptor tyrosine kinase inhibitor, AGโ013736, using dynamic contrastโenhanced MR imaging (DCEโMRI). ## Materials and Methods